Mustang Bio, Inc.
(NASDAQ:MBIO)
$1.53
-0.10 (-6.13%)
At Close: 4:00 PM
MBIO Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
MBIO Stock Price Today
Mustang Bio, Inc. (MBIO) stock declined over -1.92% intraday to trade at $1.53 a share on NASDAQ. The stock opened with a loss of -15.95% at $1.37 and touched an intraday high of $1.57, falling -6.13% against the last close of $1.63. The Mustang Bio, Inc. in stock market went to a low of $1.34 during the session.
MBIO Stock Snapshot
$1.63
Prev. Close
14.11 Million
Market Cap
$1.34
Day Low
$1.37
Open
N/A
Number of Shares
$1.57
Day High
N/A
P/E ratio
-8.03
EPS (TTM)
1.04
Cash Flow per Share
N/A
Free Float in %
0.49
Book Value
55392.00
Volume
MBIO Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.81
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
Peers
Frequently Asked Questions
What is the current Mustang Bio, Inc. (MBIO) stock price?
Mustang Bio, Inc. (NASDAQ: MBIO) stock price is $1.53 in the last trading session. During the trading session, MBIO stock reached the peak price of $1.57 while $1.34 was the lowest point it dropped to. The percentage change in MBIO stock occurred in the recent session was -1.92% while the dollar amount for the price change in MBIO stock was -$0.03.
MBIO's industry and sector of operation?
The NASDAQ listed MBIO is part of Biotechnology industry that operates in the broader Healthcare sector. Mustang Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases.
Who are the executives of MBIO?
Dr. Manuel Litchman M.D.
Pres, Chief Executive Officer & Director
Mr. Greg Furrow M.S.
Senior Vice President of Quality
Mr. Matthew Wein J.D.
Vice President & Gen. Counsel
Dr. Knut Niss
Chief Technology Officer
How MBIO did perform over past 52-week?
MBIO's closing price is 0.49% higher than its 52-week low of $1.25 where as its distance from 52-week high of $11.085 is -0.70%.
How many employees does MBIO have?
Number of MBIO employees currently stands at N/A. MBIO operates from 377 Plantation Street, Worcester, MA 01605, US.
Link for MBIO official website?
Official Website of MBIO is: https://www.mustangbio.com
How do I contact MBIO?
MBIO could be contacted at phone #781 652 4500 and can also be accessed through its website. MBIO operates from 377 Plantation Street, Worcester, MA 01605, US.
How many shares of MBIO are traded daily?
MBIO stock volume for the day was 55392.00 shares. The average number of MBIO shares traded daily for last 3 months was 79.63 Thousands.
What is the market cap of MBIO currently?
The market value of MBIO currently stands at $14.11 Million with its latest stock price at $1.53 and N/A of its shares outstanding.